FORTIS HEALTHCARE LTD. has acquired a total of 31.52% stake in Agilus Diagnostics Limited from various investors, raising its ownership to 89.2%. The company acquired 1,24,37,811 shares from NJBIF and 63,10,315 shares from Resurgence PE Investments, expected to complete by January 20, 2025.